Radiotherapeutic Management of Prostate Adenocarcinoma
Author | : | |
Rating | : | 4.52 (544 Votes) |
Asin | : | 0340741104 |
Format Type | : | paperback |
Number of Pages | : | 208 Pages |
Publish Date | : | 2014-09-25 |
Language | : | English |
DESCRIPTION:
The text reviews 3D conformal radiotherapy and looks at the role of protons, neutrons, ultrasound and MRI guided prostate brachytherapy in the management of localised disease, and the value of hormonal and other novel therapies in the treatment of locally advanced disease. Both technical and clinical aspects of external and internal radiation therapy for all stages of prostate cancer are considered. Outcome prediction following treatment is also discussed.This comprehensive text, edited by acknowledged international experts, will be an invaluable addition to the bookshelves of any radiotherapy department.. Adenocarcinoma of the prostate has become the most frequently diagnosed cancer in men over the age of 50. This timely book outlines prostate cancer staging and focuses on the latest treatments in radiotherapy, including the development of new techniques which allow the radiation oncologist to target the tumour more precisely while simultaneously minimizing the radiation reaching normal juxtaposed tissues such as the rectum and urethra
Anthony V. Hanks, Professor and Chairman, Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia. . D'Amico, Assistant Professor of Radiation Oncology, Harvard Medical School, Boston. Gerald E.H
I am extreemly happy I bought this book, A Customer This book is the best book that i have seen in the subjects that covers(Radiotherapotic management of prostate adenocarcinoma).
Certainly the radiation and surgical oncologists have to be aware of new treatments and work together on these cases. Any book that highlights new treatment methods would be welcome. Dr. Hanks is still considered one of the top two or three people in this area. The diagnosis and treatment of prostate cancer have always been controversial, now more than ever as there are some significantly new methods of treatment. The group at Harvard should do a terrific job on this.Howard Silberman, Professor of Sur